1. WHO. WHO Public Health Research Agenda for Influenza, Background Document, Stream 4, 2018 [http://apps.who.int/iris/bitstream/handle/10665/259887/WHO-WHE-IHM-GIP-2017.7-eng.pdf?sequence=1.
2. Widespread use of neuraminidase inhibitors in Japan;N Sugaya;J Infect Chemother,2011
3. Ministry of Health, Labour and Welfare. Countermeasures for influenza epidemic of Japan (in Japanese) 2019 [https://www.mhlw.go.jp/bunya/kenkou/influenza/.
4. Baloxavir Marboxil for Uncomplicated Influenza in Adults and Adolescents;FG Hayden;N Engl J Med,2018
5. Very low pandemic influenza A (H1N1) 2009 mortality associated with early neuraminidase inhibitor treatment in Japan: Analysis of 1000 hospitalized children;N Sugaya;J Infect,2011